Del Rosso, J. ., Yosipovitch, G. ., Ständer, S. ., Silverberg, J. ., Wollenberg, A. ., Lio, P. A. ., Carrascosa, J. M. ., Gallo, G. ., Casillas, M. ., Pierce, E. ., Ding, Y. ., Xu, Z. ., Agell, H. ., & Stein Gold, L. . (2023). Lebrikizumab Provides Stable Itch Response With No or Minimal Fluctuations up to One Year in Patients With Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, 7(6), s282. https://doi.org/10.25251/skin.7.supp.282